Clinical Trials Directory

Trials / Completed

CompletedNCT02805270

Impact of Medication Reconciliation Intervention on the Rate of Preventable Adverse Drug Events (ADEs) and Healthcare Utilization

Implementation of a Medication Reconciliation Intervention and Its Impact on the Rate of ADEs and Healthcare Utilization 30 Days Following Discharge From the Hospital. A Randomized Controlled Trial.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
587 (actual)
Sponsor
Sultan Qaboos University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The implementation of a medication reconciliation intervention including: medication reconciliation on admission and discharge, bedside medication counselling and take-home medication list, on the development of adverse drug events within 30 days post discharge as primary outcome. Secondary outcome is the evaluation of its impact on health care resource utilization

Detailed description

This is a randomized controlled trial in 587 patients randomized to intervention and usual care. The intervention is medication reconciliation on admission and discharge, bedside medication counselling and take-home medication list. Usual care is ward pharmacy practice. The primary outcomes are preventable and potential adverse drug events at 30 days post discharge. The secondary outcome is health care utilization: length of stay, emergency room visits, unplanned hospital visits, readmissions and travel abroad to seek medical attention.

Conditions

Interventions

TypeNameDescription
OTHERmedication reconciliation interventionmedication reconciliation intervention comprises medication reconciliation on admission and discharge, bedside medication counseling and take-home medication list

Timeline

Start date
2014-01-01
Primary completion
2015-02-01
Completion
2015-02-01
First posted
2016-06-17
Last updated
2016-06-21

Source: ClinicalTrials.gov record NCT02805270. Inclusion in this directory is not an endorsement.